UTHR United Therapeutics Corporation
$559.10
United Therapeutics Corporation (UTHR) Earnings News
Earnings press releases, previews and reviews for United Therapeutics Corporation (UTHR), newest first. Our most recent is review: United Therapeutics Misses on EPS as Thymmune Charge Obscures Record Revenue and a Tyvaso Reacceleration.
Wednesday
November 4, 2026
4:07 PM ET
United Therapeutics Misses on EPS as Thymmune Charge Obscures Record Revenue and a Tyvaso Reacceleration
Earnings Whispers · Review
Wednesday
November 4, 2026
6:30 AM ET
United Therapeutics Corporation Reports Third Quarter 2026 Financial Results
Tuesday
October 27, 2026
3:00 PM ET
United Therapeutics Must Show Tyvaso Can Hold Ground as Rally Outpaces Sentiment
Earnings Whispers · Preview
Wednesday
October 21, 2026
7:00 AM ET
United Therapeutics Corporation to Report Third Quarter 2026 Financial Results Before Market Open on Wednesday, November 4, 2026
Wednesday
August 5, 2026
6:30 AM ET
United Therapeutics Corporation Reports Second Quarter 2026 Financial Results
Wednesday
July 22, 2026
7:00 AM ET
United Therapeutics Corporation to Report Second Quarter 2026 Financial Results Before Market Open on Wednesday, August 5, 2026